CN103534208A - 无机粒子材料的制造方法 - Google Patents
无机粒子材料的制造方法 Download PDFInfo
- Publication number
- CN103534208A CN103534208A CN201280023311.9A CN201280023311A CN103534208A CN 103534208 A CN103534208 A CN 103534208A CN 201280023311 A CN201280023311 A CN 201280023311A CN 103534208 A CN103534208 A CN 103534208A
- Authority
- CN
- China
- Prior art keywords
- agent
- mesoporous
- gel
- particulate material
- biologically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 56
- 239000011236 particulate material Substances 0.000 title claims abstract description 31
- 239000000463 material Substances 0.000 claims abstract description 46
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 81
- 239000013543 active substance Substances 0.000 claims description 41
- 239000003795 chemical substances by application Substances 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 35
- 239000002245 particle Substances 0.000 claims description 31
- 238000003756 stirring Methods 0.000 claims description 29
- 239000003814 drug Substances 0.000 claims description 28
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 25
- 239000002904 solvent Substances 0.000 claims description 24
- 239000002243 precursor Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 239000011148 porous material Substances 0.000 claims description 14
- 239000004202 carbamide Substances 0.000 claims description 13
- 238000006460 hydrolysis reaction Methods 0.000 claims description 13
- 125000002524 organometallic group Chemical group 0.000 claims description 12
- 230000007062 hydrolysis Effects 0.000 claims description 11
- 239000011159 matrix material Substances 0.000 claims description 11
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 10
- 239000003826 tablet Substances 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 8
- 239000007943 implant Substances 0.000 claims description 8
- 238000011200 topical administration Methods 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 229920003169 water-soluble polymer Polymers 0.000 claims description 7
- 125000003368 amide group Chemical group 0.000 claims description 6
- 230000004048 modification Effects 0.000 claims description 6
- 238000012986 modification Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 5
- 239000000375 suspending agent Substances 0.000 claims description 5
- 230000007704 transition Effects 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 238000007669 thermal treatment Methods 0.000 claims description 3
- 230000001788 irregular Effects 0.000 claims description 2
- 239000012867 bioactive agent Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- 239000000377 silicon dioxide Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 238000009826 distribution Methods 0.000 description 17
- 229910010272 inorganic material Inorganic materials 0.000 description 15
- 239000011147 inorganic material Substances 0.000 description 15
- 235000012239 silicon dioxide Nutrition 0.000 description 15
- -1 polyoxyethylene Polymers 0.000 description 14
- 229960001866 silicon dioxide Drugs 0.000 description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 13
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 229960004130 itraconazole Drugs 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 239000002351 wastewater Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 238000001354 calcination Methods 0.000 description 8
- 238000012377 drug delivery Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000032683 aging Effects 0.000 description 7
- 150000004703 alkoxides Chemical class 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 238000003825 pressing Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 6
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 6
- 238000003795 desorption Methods 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 229910017604 nitric acid Inorganic materials 0.000 description 6
- 238000000197 pyrolysis Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229910000765 intermetallic Inorganic materials 0.000 description 5
- 229910052753 mercury Inorganic materials 0.000 description 5
- 239000013335 mesoporous material Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 229960001680 ibuprofen Drugs 0.000 description 4
- 239000004973 liquid crystal related substance Substances 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 239000005662 Paraffin oil Substances 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- MWRWFPQBGSZWNV-UHFFFAOYSA-N Dinitrosopentamethylenetetramine Chemical compound C1N2CN(N=O)CN1CN(N=O)C2 MWRWFPQBGSZWNV-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229920000831 ionic polymer Polymers 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 235000010603 pastilles Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 238000002459 porosimetry Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000005201 scrubbing Methods 0.000 description 2
- 125000005372 silanol group Chemical group 0.000 description 2
- 239000002210 silicon-based material Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 238000003980 solgel method Methods 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229920000428 triblock copolymer Polymers 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 238000004438 BET method Methods 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 1
- SBRXLTRZCJVAPH-UHFFFAOYSA-N ethyl(trimethoxy)silane Chemical compound CC[Si](OC)(OC)OC SBRXLTRZCJVAPH-UHFFFAOYSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical group 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910001510 metal chloride Inorganic materials 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229920002114 octoxynol-9 Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- VDGJOQCBCPGFFD-UHFFFAOYSA-N oxygen(2-) silicon(4+) titanium(4+) Chemical compound [Si+4].[O-2].[O-2].[Ti+4] VDGJOQCBCPGFFD-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 125000003884 phenylalkyl group Chemical group 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910021426 porous silicon Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000003340 retarding agent Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 1
- 230000009645 skeletal growth Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- XQMTUIZTZJXUFM-UHFFFAOYSA-N tetraethoxy silicate Chemical compound CCOO[Si](OOCC)(OOCC)OOCC XQMTUIZTZJXUFM-UHFFFAOYSA-N 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940100615 topical ointment Drugs 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229930195724 β-lactose Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
- C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
- C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
- C01B33/141—Preparation of hydrosols or aqueous dispersions
- C01B33/142—Preparation of hydrosols or aqueous dispersions by acidic treatment of silicates
- C01B33/143—Preparation of hydrosols or aqueous dispersions by acidic treatment of silicates of aqueous solutions of silicates
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
- C01B33/18—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
- C01B33/18—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
- C01B33/187—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof by acidic treatment of silicates
- C01B33/193—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof by acidic treatment of silicates of aqueous solutions of silicates
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Silicon Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11003961 | 2011-05-13 | ||
EP11003961.7 | 2011-05-13 | ||
PCT/EP2012/001769 WO2012156023A1 (en) | 2011-05-13 | 2012-04-25 | Process for producing inorganic particulate material |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103534208A true CN103534208A (zh) | 2014-01-22 |
CN103534208B CN103534208B (zh) | 2017-07-18 |
Family
ID=46022158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280023311.9A Expired - Fee Related CN103534208B (zh) | 2011-05-13 | 2012-04-25 | 无机粒子材料的制造方法 |
Country Status (18)
Country | Link |
---|---|
US (1) | US9517268B2 (zh) |
EP (1) | EP2707329B1 (zh) |
JP (1) | JP6040497B2 (zh) |
KR (1) | KR101906792B1 (zh) |
CN (1) | CN103534208B (zh) |
AR (1) | AR086346A1 (zh) |
AU (1) | AU2012258092B2 (zh) |
BR (1) | BR112013029149A2 (zh) |
CA (1) | CA2836782A1 (zh) |
DK (1) | DK2707329T3 (zh) |
EA (1) | EA201301264A1 (zh) |
ES (1) | ES2657822T3 (zh) |
IL (1) | IL229209A (zh) |
MX (1) | MX352176B (zh) |
PT (1) | PT2707329T (zh) |
SG (1) | SG194820A1 (zh) |
WO (1) | WO2012156023A1 (zh) |
ZA (1) | ZA201309469B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110133765A (zh) * | 2018-02-08 | 2019-08-16 | 法国圣戈班玻璃厂 | 带有耐污层的光学组件及其制备方法和应用 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10577250B2 (en) | 2011-05-13 | 2020-03-03 | Merck Patent Gmbh | Process for producing of inorganic particulate material |
PT2916829T (pt) * | 2012-11-12 | 2019-06-04 | Merck Patent Gmbh | Utilização de material baseado em óxido de silício para a libertação modificada de agentes biologicamente ativos |
KR20160089504A (ko) * | 2013-11-26 | 2016-07-27 | 메르크 파텐트 게엠베하 | 무기 미립자 재료의 제조 방법 |
JP7200097B2 (ja) | 2017-05-19 | 2023-01-06 | 株式会社トクヤマ | 医薬原体担持体及びその製造方法 |
JP7352936B2 (ja) * | 2018-08-17 | 2023-09-29 | 地方独立行政法人東京都立産業技術研究センター | 多孔質シリカ、機能材料および多孔質シリカの製造方法 |
WO2020127281A1 (en) | 2018-12-20 | 2020-06-25 | Merck Patent Gmbh | A release system comprising a bioactive agent and a particulate material |
WO2021220507A1 (ja) * | 2020-05-01 | 2021-11-04 | 昭和電工マテリアルズ株式会社 | 多孔質体形成用塗液、多孔質体及び多孔質体の製造方法 |
JP6924338B1 (ja) * | 2021-01-29 | 2021-08-25 | 三井金属鉱業株式会社 | ゾル、ゲル及びシリカ多孔体を製造する装置及び方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1298097A1 (en) * | 1996-12-26 | 2003-04-02 | MERCK PATENT GmbH | Method for producing porous inorganic materials |
CN1541186A (zh) * | 2001-08-13 | 2004-10-27 | ���ǻ�ѧ��˾ | 制备硅石的方法,具有特定孔隙尺寸和/或粒度分布的硅石和它的用途,尤其用于增强聚合物 |
CN1777411A (zh) * | 2003-02-24 | 2006-05-24 | 药品生产公司 | 经粘膜药物递送*** |
CN101113247A (zh) * | 2007-09-05 | 2008-01-30 | 广州市飞雪化工有限公司 | 一种透明磨擦粒子的制备方法 |
CN101250313A (zh) * | 2008-03-19 | 2008-08-27 | 中国科学院化学研究所 | 纳米粒子复合物及其制备方法 |
CN101343065A (zh) * | 2008-09-04 | 2009-01-14 | 复旦大学 | 一种纳米二氧化硅空心球材料及其制备方法 |
CN101348713A (zh) * | 2007-07-20 | 2009-01-21 | 同济大学 | 能发射荧光的磁性复合纳米微球及其制备方法 |
CN101412517A (zh) * | 2008-11-14 | 2009-04-22 | 华东理工大学 | 孔径可控的介孔二氧化硅微球的制备方法及应用 |
CN101559952A (zh) * | 2009-05-13 | 2009-10-21 | 南京工业大学 | 一种纳米尺度介孔二氧化硅球的制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1070216A (en) * | 1964-03-09 | 1967-06-01 | Grace W R & Co | Improvements in or relating to silica and silica-alumina gels |
JP3985170B2 (ja) * | 1996-12-26 | 2007-10-03 | 直弘 曽我 | 無機系多孔質体の製造方法 |
JP3985171B2 (ja) * | 1996-12-26 | 2007-10-03 | 直弘 曽我 | 無機系多孔質体の製造方法 |
BR9807718A (pt) * | 1997-02-24 | 2000-02-15 | Dow Corning | Géis de sìlica hidrofóbica envelhecida neutra com área de superfìcie reduzida |
JPH11292528A (ja) * | 1998-01-23 | 1999-10-26 | Naohiro Soga | 無機多孔質材料の製造法 |
DE69841079D1 (de) | 1998-01-23 | 2009-10-01 | Merck Patent Gmbh | Verfahren zur herstellung von inorganischem material in einer kapillare |
CA2380941A1 (en) * | 1999-08-16 | 2001-02-22 | Henceforth Hibernia, Inc. | Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
GB0315012D0 (en) * | 2003-06-27 | 2003-07-30 | Leuven K U Res & Dev | Zeotiles |
JP4519433B2 (ja) * | 2003-09-17 | 2010-08-04 | 株式会社トクヤマ | 微粒子状メソポーラスシリカ |
TW200525015A (en) | 2003-09-11 | 2005-08-01 | Taiyo Kagaku Kk | Porous silica having substance carried thereon |
GB0420016D0 (en) | 2004-09-09 | 2004-10-13 | Leuven K U Res & Dev | Controlled release oral delivery system |
US20070224133A1 (en) | 2006-03-23 | 2007-09-27 | Mcgill Patrick D | High-cleaning silica materials made via product morphology control under high shear conditions |
JP2009013142A (ja) * | 2007-07-09 | 2009-01-22 | Kyoto Univ | 徐放用メソポーラスシリカ |
JP5426869B2 (ja) * | 2008-11-19 | 2014-02-26 | パナソニック株式会社 | メソポーラスシリカ微粒子の製造方法、メソポーラスシリカ微粒子含有組成物、及びメソポーラスシリカ微粒子含有成型物 |
JP4521477B1 (ja) * | 2009-01-15 | 2010-08-11 | 水澤化学工業株式会社 | 非晶質シリカ |
CN101829331A (zh) * | 2010-05-28 | 2010-09-15 | 沈阳药科大学 | 一种适用于难溶性药物的三维有序大孔二氧化硅给药体系 |
-
2012
- 2012-04-25 MX MX2013013135A patent/MX352176B/es active IP Right Grant
- 2012-04-25 CA CA2836782A patent/CA2836782A1/en not_active Abandoned
- 2012-04-25 DK DK12717608.9T patent/DK2707329T3/en active
- 2012-04-25 ES ES12717608.9T patent/ES2657822T3/es active Active
- 2012-04-25 WO PCT/EP2012/001769 patent/WO2012156023A1/en active Application Filing
- 2012-04-25 EA EA201301264A patent/EA201301264A1/ru unknown
- 2012-04-25 KR KR1020137033128A patent/KR101906792B1/ko active IP Right Grant
- 2012-04-25 EP EP12717608.9A patent/EP2707329B1/en not_active Not-in-force
- 2012-04-25 AU AU2012258092A patent/AU2012258092B2/en not_active Ceased
- 2012-04-25 SG SG2013082342A patent/SG194820A1/en unknown
- 2012-04-25 BR BR112013029149A patent/BR112013029149A2/pt not_active Application Discontinuation
- 2012-04-25 CN CN201280023311.9A patent/CN103534208B/zh not_active Expired - Fee Related
- 2012-04-25 PT PT127176089T patent/PT2707329T/pt unknown
- 2012-04-25 US US14/117,041 patent/US9517268B2/en not_active Expired - Fee Related
- 2012-04-25 JP JP2014509629A patent/JP6040497B2/ja not_active Expired - Fee Related
- 2012-05-11 AR ARP120101657A patent/AR086346A1/es active IP Right Grant
-
2013
- 2013-11-03 IL IL229209A patent/IL229209A/en active IP Right Grant
- 2013-12-12 ZA ZA2013/09469A patent/ZA201309469B/en unknown
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1298097A1 (en) * | 1996-12-26 | 2003-04-02 | MERCK PATENT GmbH | Method for producing porous inorganic materials |
CN1541186A (zh) * | 2001-08-13 | 2004-10-27 | ���ǻ�ѧ��˾ | 制备硅石的方法,具有特定孔隙尺寸和/或粒度分布的硅石和它的用途,尤其用于增强聚合物 |
CN1777411A (zh) * | 2003-02-24 | 2006-05-24 | 药品生产公司 | 经粘膜药物递送*** |
CN101348713A (zh) * | 2007-07-20 | 2009-01-21 | 同济大学 | 能发射荧光的磁性复合纳米微球及其制备方法 |
CN101113247A (zh) * | 2007-09-05 | 2008-01-30 | 广州市飞雪化工有限公司 | 一种透明磨擦粒子的制备方法 |
CN101250313A (zh) * | 2008-03-19 | 2008-08-27 | 中国科学院化学研究所 | 纳米粒子复合物及其制备方法 |
CN101343065A (zh) * | 2008-09-04 | 2009-01-14 | 复旦大学 | 一种纳米二氧化硅空心球材料及其制备方法 |
CN101412517A (zh) * | 2008-11-14 | 2009-04-22 | 华东理工大学 | 孔径可控的介孔二氧化硅微球的制备方法及应用 |
CN101559952A (zh) * | 2009-05-13 | 2009-10-21 | 南京工业大学 | 一种纳米尺度介孔二氧化硅球的制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110133765A (zh) * | 2018-02-08 | 2019-08-16 | 法国圣戈班玻璃厂 | 带有耐污层的光学组件及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
JP6040497B2 (ja) | 2016-12-07 |
KR101906792B1 (ko) | 2018-10-11 |
IL229209A0 (en) | 2014-01-30 |
AR086346A1 (es) | 2013-12-04 |
JP2014522363A (ja) | 2014-09-04 |
WO2012156023A1 (en) | 2012-11-22 |
SG194820A1 (en) | 2013-12-30 |
EA201301264A1 (ru) | 2014-04-30 |
PT2707329T (pt) | 2018-02-07 |
IL229209A (en) | 2016-12-29 |
KR20140033122A (ko) | 2014-03-17 |
US9517268B2 (en) | 2016-12-13 |
EP2707329B1 (en) | 2017-11-01 |
CA2836782A1 (en) | 2012-11-22 |
BR112013029149A2 (pt) | 2017-02-07 |
DK2707329T3 (en) | 2018-01-15 |
US20140336274A1 (en) | 2014-11-13 |
WO2012156023A8 (en) | 2014-01-30 |
ZA201309469B (en) | 2014-08-27 |
MX352176B (es) | 2017-11-13 |
ES2657822T3 (es) | 2018-03-07 |
EP2707329A1 (en) | 2014-03-19 |
MX2013013135A (es) | 2014-02-11 |
AU2012258092B2 (en) | 2015-08-20 |
CN103534208B (zh) | 2017-07-18 |
AU2012258092A1 (en) | 2014-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103534208A (zh) | 无机粒子材料的制造方法 | |
US7563451B2 (en) | Capped mesoporous silicates | |
JP6557745B2 (ja) | 生物活性物質の改変放出のための酸化ケイ素ベース材料の使用 | |
CN103086346B (zh) | 一种介孔碳的制备方法与应用 | |
CN104650091B (zh) | 替格瑞洛的微粉化及其晶型,以及制备方法和药物应用 | |
KR100814730B1 (ko) | 나노-매크로 사이즈의 계층적 기공구조를 가지는 다공성 생체활성유리 및 이의 합성방법 | |
CN101214965A (zh) | 一种大孔-介孔二氧化硅空心微球制备方法和应用 | |
CN102066256A (zh) | 有序中孔氧化硅材料 | |
JP2007523817A (ja) | 薬物を固定および制御放出するために有用な結晶性メソポーラス酸化物を基剤とする材料 | |
CN105764852A (zh) | 用于生产无机颗粒材料的方法 | |
CN106622377A (zh) | 一种球形含铝介孔复合材料和负载型催化剂及其制备方法和应用以及乙酸乙酯的制备方法 | |
CN101880405A (zh) | 一种生物可降解球形多孔淀粉泡沫的制备方法与应用 | |
CN106924193A (zh) | 一种高孔隙率干粉吸入剂载体及其超饱和合成法和应用 | |
US10577250B2 (en) | Process for producing of inorganic particulate material | |
Liang et al. | Construction and properties of venlafaxine hydrochloride sustained release system based on hollow mesoporous silica microspheres | |
Sheeba et al. | Mesoporous Santa Barbara Amorphous For Novel Drug Delivery System |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Mario Mayo Inventor after: Eugenia Breninger Inventor after: Carin Cabrera Perez Inventor after: Ulrich Lange Inventor after: Benjamin Peters Inventor after: Thomas Puchert Inventor after: Christopher Sarr Inventor after: Michael Schulze Inventor before: Mario Mayo Inventor before: Eugenia Breningen Inventor before: Karin Cabrera Perez Inventor before: Ulrich Lange Inventor before: Benjamin Peters Inventor before: Thomas Puchert Inventor before: Christopher Sar Inventor before: Michael Schulze |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: MAIO MARIO BREININGEN EUGENIA CABRERA PEREZ KARIN ULRICH LANG PETERS BENJAMIN PUCHERT THOMAS SAAL CHRISTOPH SCHULZ MICHAEL TO: MAIO MARIO BREININGER EUGENIA CABRERA PEREZ KARIN ULRICH LANG PETERS BENJAMIN PUCHERT THOMAS SAAL CHRISTOPH SCHULZ MICHAEL |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1188593 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1188593 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170718 Termination date: 20210425 |
|
CF01 | Termination of patent right due to non-payment of annual fee |